InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Alpha Cognition Inc.

ACOG Clue Score46
United States Fiscal year ends December CIK 0001655923
$9.04 +0.00% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $9.04 +19.42% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Nov 2024. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2023Operating income−9.9Net income−13.8EPS, diluted−3.84Fiscal year 2024Operating income−12.0Net income−14.8EPS, diluted−2.04Fiscal year 2025Revenue10.2Operating income−22.7Net income−20.7EPS, diluted−1.18
FY2023FY2024FY2025
Revenue n/a n/a 10.2
Growth
Operating income −9.9 −12.0 −22.7
Net income −13.8 −14.8 −20.7
Growth
EPS, diluted −3.84 −2.04 −1.18

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2023Fiscal year 2024Fiscal year 2025Operating margin−221.7%Net margin−202.2%Free cash flow margin−202.3%
FY2023FY2024FY2025
Operating margin n/a n/a −221.7%
Net margin n/a n/a −202.2%
Free cash flow margin n/a n/a −202.3%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2023Operating cash flow−8.8Fiscal year 2024Operating cash flow−7.8Capital expenditure−0.0Free cash flow−7.8Fiscal year 2025Operating cash flow−20.4Capital expenditure−0.3Free cash flow−20.7
FY2023FY2024FY2025
Operating cash flow −8.8 −7.8 −20.4
Capital expenditure n/a −0.0 −0.3
Free cash flow n/a −7.8 −20.7
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2023Cash1.4Shareholders’ equity−4.7Fiscal year 2024Cash48.5Shareholders’ equity39.1Fiscal year 2025Cash66.0Shareholders’ equity62.5
FY2023FY2024FY2025
Cash 1.4 48.5 66.0
Shareholders’ equity −4.7 39.1 62.5

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
n/a n/a −221.7%
n/a n/a −202.2%
n/a n/a −202.3%
Spending
n/a n/a 18.3%
n/a n/a 284.5%
n/a n/a 2.9%
Returns
n/a −37.8% −33.1%
−561.3% −29.1% −25.9%
Balance and payout
291.8% 22.9% 21.6%